.webp)
The global circulating biomarkers market size is calculated at USD 5.17 billion in 2025 and is predicted to increase from USD 5.78 billion in 2026 to approximately USD 14.22 billion by 2034, expanding at a CAGR of 11.90% from 2025 to 2034. The global circulating biomarkers market is experiencing robust growth, driven by the increasing prevalence of chronic disease diagnostics, growing demand for personalized medicine, a surge in regulatory approvals, increasing need for early & non-invasive detection methods, and rising investments in healthcare infrastructure. This report covers market trends, production volumes, technological developments, and competitive dynamics across North America, Europe, and APAC between 2025 and 2030."
The global incretin mimetics market size is calculated at USD 24.36 billion in 2025 and is predicted to increase from USD 25.59 billion in 2026 to approximately USD 38.01 billion by 2034, expanding at a CAGR of 5.07% from 2025 to 2034. The market for incretin mimetics stands as a transformative frontier in diabetic care, blending pharmacological precision with physiological harmony. As metabolic disorders continue to escalate worldwide, these agents are designed to mimic natural incretin hormones.
The global gel documentation systems market size is calculated at USD 373.87 million in 2025 and is predicted to increase from USD 396.98 million in 2026 to approximately USD 641.37 million by 2034, expanding at a CAGR of 6.18% from 2025 to 2034. The market growth is attributed to the expanding adoption of advanced imaging technologies in molecular biology and clinical diagnostics.
The global next-generation sequencing library preparation market size is calculated at USD 2.07 billion in 2025 and is predicted to increase from USD 2.34 billion in 2026 to approximately USD 6.44 billion by 2034, expanding at a CAGR of 13.47% from 2025 to 2034. This market is growing due to increasing demand for precise genomic analysis and advancements in sequencing technologies.
The global Type 2 diabetes management market uncovers key drivers such as increasing healthcare expenditure, aging populations and regulatory support for diabetes education and self-management programs. The market is witnessing remarkable growth as global health systems increasingly prioritize chronic disease prevention and personalized care.
The global dermo cosmetics market size is calculated at USD 48.76 billion in 2025 and is predicted to increase from USD 53.84 billion in 2026 to approximately USD 118.99 billion by 2034, expanding at a CAGR of 10.42% from 2025 to 2034. increasing consumer awareness of skin health and a rise in chronic skin conditions like acne and eczema.
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs. The growth of the market is driven by rising diabetes prevalence and growing demand for simplified, effective combination therapies.
The global SGLT-2 inhibitors market size is calculated at USD 18.18 billion in 2025 and is predicted to increase from USD 19.31 billion in 2026 to approximately USD 31.34 billion by 2034, expanding at a CAGR of 6.24% from 2025 to 2034. The SGLT-2 inhibitors market is driven by rising diabetes prevalence, expanding therapeutic applications, and increasing adoption of combination therapies globally.
The global minimal residual disease (MRD) testing market size is calculated at USD 1.70 billion in 2025 and is predicted to increase from USD 1.91 billion in 2026 to approximately USD 4.72 billion by 2034, expanding at a CAGR of 12.00% from 2025 to 2034. The market is experiencing substantial growth due to the rising prevalence of cancer, the shift toward personalized medicine, and the increased use of MRD testing in clinical trials. Market growth is significantly driven by demand for highly sensitive technologies like next-generation sequencing (NGS) and digital PCR (dPCR), which accurately detect minimal residual cancer cells to guide treatment decisions and predict patient outcomes.
The global circulating tumor DNA (ctDNA) market size is calculated at USD 7.96 billion in 2025 and is predicted to increase from USD 9.14 billion in 2026 to approximately USD 27.67 billion by 2034, expanding at a CAGR of 14.85% from 2025 to 2034. Growth in precision oncology, demand for targeted therapies, and advancements in next-generation sequencing (NGS) technology are driving the growth of the circulating tumor DNA (ctDNA) market.
The global feline vaccines market size is calculated at USD 1.77 billion in 2025 and is predicted to increase from USD 1.89 billion in 2026 to approximately USD 3.28 billion by 2034, expanding at a CAGR of 7.12% from 2025 to 2034. The global feline vaccines market is witnessing robust growth, driven by rising pet humanization trends, rising pet ownership, increasing awareness of preventative healthcare for cats, and significant investments in veterinary healthcare infrastructure. This report covers market trends, production volumes, technological developments, and competitive dynamics across North America, Europe, and APAC between 2025 and 2030.
The global microbiology and bacterial culture media market size accounted for USD 6.03 billion in 2025 and is predicted to increase from USD 6.58 billion in 2026 to approximately USD 13.22 billion by 2034, expanding at a CAGR of 9.11% from 2025 to 2034. The microbiology and bacterial culture media market is driven by rising infectious diseases, rigorous food and pharmaceutical safety regulations, technological advancements, and increased R&D in biotechnology and vaccine development.
The global bioprocess validation market size is calculated at USD 537.30 million in 2025 and is predicted to increase from USD 586.36 million in 2026 to approximately USD 1,179.55 million by 2034, expanding at a CAGR of 9.13% from 2025 to 2034. The market is experiencing substantial growth due to the increasing adoption of advanced biomanufacturing technologies, including cell and gene therapies. This demand is further fueled by the need for platforms capable of aggregating and analyzing multi-source data in real time to support Continued Process Verification (CPV) and meet regulatory compliance requirements. The integration of smart sensors (IoT) and AI is accelerating workflow automation and process optimization, ensuring consistent product quality and safety.
The global human fibrinogen concentrates market size is calculated at USD 1.33 billion in 2025 and is predicted to increase from USD 1.43 billion in 2026 to approximately USD 2.50 billion by 2034, expanding at a CAGR of 7.26% from 2025 to 2034. The increased numbers of surgical procedures and prevalence of bleeding disorders are driving the growth of the human fibrinogen concentrates market.
The global minimally invasive medical imaging market driven by rising chronic disease prevalence, technological innovations in ultrasound/CT/MRI and growing patient demand for less traumatic diagnostics. The minimally invasive medical imaging market growth is driven by the increasing preference for minimally invasive surgeries, technological advancements in imaging systems, and a rising demand for early and accurate diagnostics.
The global flash chromatography market size was calculated at USD 264.94 million in 2025 and is predicted to increase from USD 278.38 million in 2026 to approximately USD 413.49 million by 2034, expanding at a CAGR of 5.07% from 2025 to 2034. The market stands as a cornerstone of modern separation science, enabling swift and efficient purification of chemical mixtures in laboratories worldwide.
The global induced pluripotent stem cell (iPSC) therapy market growth is fueled by stem-cell R&D funding, clinical translation of iPSC therapeutics and expanding cell-therapy pipelines. The market is witnessing substantial growth due to increasing demand for personalized medicine and regenerative therapies for chronic diseases. Its expansion is further fueled by technological advances that enhance iPSC production efficiency and scalability. Additionally, the integration of AI and machine learning is accelerating research and development, propelling market growth.
The global restorative dentistry market size is calculated at USD 24.60 billion in 2025 and is predicted to increase from USD 26.55 billion in 2026 to approximately USD 48.93 billion by 2034, expanding at a CAGR of 7.94% from 2025 to 2034. Restorative dentistry focuses on repairing and restoring damaged teeth to improve oral health and functionality. It encompasses various treatments aimed at restoring the natural appearance and strength of teeth, contributing to overall dental wellness.
The global EEG-based biometrics market size was calculated at USD 2.74 billion in 2025 and is predicted to increase from USD 2.98 billion in 2026 to approximately USD 5.94 billion by 2034, expanding at a CAGR of 9.00% from 2025 to 2034. The increased demand for secure and efficient biometric solutions is driving the global market. Growing emphasis on health monitoring is further contributing to this growth.
The global in-silico drug discovery market size was calculated at USD 4.17 billion in 2025 and is predicted to increase from USD 4.63 billion in 2026 to approximately USD 10.73 billion by 2034, expanding at a CAGR of 11.09% from 2025 to 2034.
The global active pharmaceutical ingredients CDMO market size was calculated at USD 116.77 billion in 2025 and is predicted to increase from USD 125.99 billion in 2026 to approximately USD 231.48 billion by 2034, expanding at a CAGR of 7.90% from 2025 to 2034. The market is experiencing significant growth, as pharmaceutical companies are outsourcing API manufacturing to reduce costs and scale production. Additionally, rising demand for complex APIs, such as biologics and highly potent compounds, along with the need to diversify supply chains, mitigate risks, enhance operational efficiency, and accelerate time-to-market, are fueling further expansion.
The global oral solid dose oncology CDMO market is driven by growing demand for efficient, scalable cancer drug manufacturing and formulation support. The market is experiencing significant growth, driven by the rising demand for effective cancer treatments in solid dosage forms. With an increasing number of oncology therapies being developed and launched, contract development and manufacturing organizations (CDMOs) play a crucial role in supporting pharmaceutical companies. This dynamic market is anticipated to expand from its current valuation, reaching impressive figures over the next decade.
The global mental health digital therapeutics (DTx) market is witnessing rapid growth as digital platforms deliver clinically validated treatments for mental health conditions. This market is growing due to increasing awareness about mental well-being and the rising adoption of technology-driven, accessible treatment solutions.
The global regenerative aesthetics market size was calculated at USD 3.76 billion in 2025 and is predicted to increase from USD 4.04 billion in 2026 to approximately USD 7.15 billion by 2034, expanding at a CAGR of 7.40% from 2025 to 2034. The regenerative aesthetics market is a rapidly growing sector focused on advanced cosmetic and medical treatments aimed at tissue repair and rejuvenation. It is shaping the future of aesthetic procedures by emphasizing innovative, minimally invasive solutions that promote natural beauty.
The global quantum sensing medical imaging market size accounted for USD 344.23 million in 2025 and is predicted to increase from USD 370.11 million in 2026 to approximately USD 661.07 million by 2034, expanding at a CAGR of 7.52% from 2025 to 2034. This market is growing due to the unprecedented precision and sensitivity of quantum sensors.
The global psychedelic API market size was calculated at USD 4.75 billion in 2025 and is predicted to increase from USD 5.47 billion in 2026 to approximately USD 16.93 billion by 2034, expanding at a CAGR of 15.18% from 2025 to 2034. The global psychedelic API market experiencing significant growth, driven by increasing clinical research, expanding therapeutic applications, and rising interest in mental health treatments using psychedelics.
The global psychedelic therapeutics market size was estimated at USD 2.94 billion in 2025 and is predicted to increase from USD 3.41 billion in 2026 to approximately USD 11.03 billion by 2034, expanding at a CAGR of 15.82% from 2025 to 2034. The psychedelic therapeutics market is rapidly emerging as a transformative frontier in mental health treatment, driven by growing clinical validation and regulatory momentum for psychedelic-assisted therapies.
The global regenerative medicine in dermatology market offers insights into innovations in stem cell, exosome, and tissue engineering approaches for skin rejuvenation. The market is witnessing substantial growth due to rising skin condition prevalence, from chronic wounds to aesthetic concerns, and demand for advanced treatments. Innovations in cell therapies and bioengineered skin offer improved healing and appearance, while personalized products expand applications beyond aesthetics.
The global precision dermatology market is transforming dermatological care by enabling customized treatment plans for conditions like psoriasis, acne, and eczema. Technological advancements in laser and light-based skin treatments and digital imaging are fueling the growth of the global precision dermatology market.
The global T-cell imunotherapy market size accounted for USD 8.43 billion in 2025 and is predicted to increase from USD 9.57 billion in 2026 to approximately USD 26.53 billion by 2034, expanding at a CAGR of 13.59% from 2025 to 2034. The T-cell immunotherapy market is driven by the rising prevalence of cancer, advancements in T-cell engineering technologies, and increasing clinical adoption of personalized, targeted immunotherapies.
The global bispecific antibodies CDMO market is witnessing strong growth as CDMOs provide end-to-end services for complex antibody design, development, and production. The growth of the market is driven by rising demand for targeted cancer therapies, increasing biologics development, and growing outsourcing of complex antibody manufacturing.
The global neoantigen cancer vaccine market size was calculated at USD 475.68 million in 2025 and is predicted to increase from USD 551.46 million in 2026 to approximately USD 1,799.21 million by 2034, expanding at a CAGR of 15.93% from 2025 to 2034. Increased prevalence of cancer led to an increased death rate across the globe, prompting governments around the world to heavily invest in innovative therapies and the development of vaccines, like neoantigen cancer vaccine, supporting the market growth.
The global preeclampsia diagnostics market size accounted for USD 1.29 billion in 2025 and is predicted to increase from USD 1.33 billion in 2026 to approximately USD 1.70 billion by 2034, expanding at a CAGR of 3.10% from 2025 to 2034. The market is expanding due to rising awareness of maternal health, technological advancements in point-of-care testing, and increasing prenatal screening initiatives.
The global lyophilized oncology drug market is witnessing steady growth as freeze-dried formulations improve drug stability, solubility, and shelf life in cancer therapies. The market is witnessing substantial growth due to the increasing complexity of cancer therapies and the critical demand for precise, effective, and transportable cancer treatments. This growth is further accelerated by advancements in biopharmaceutical research, which are producing a growing pipeline of innovative, yet delicate, biologic drugs that require the enhanced stability and extended shelf-life provided by lyophilization.
The global checkpoint inhibitor biologics CDMO market is witnessing strong growth as pharmaceutical firms outsource biologics development to enhance efficiency and reduce time-to-market. The market for checkpoint inhibitor biologics CDMOs is witnessing remarkable growth, fueled by advancements in cancer treatment and a rising demand for personalized therapies. As the landscape of biologics continues to evolve, this market is poised for significant expansion, reflecting the increasing importance of checkpoint inhibitors in modern medicine.
The global RNA interference drug delivery market size was calculated at USD 118.18 billion in 2025 and is predicted to increase from USD 139.58 billion in 2026 to approximately USD 528.60 billion by 2034, expanding at a CAGR of 18.11% from 2025 to 2034. The in vivo cell reprogramming market is experiencing significant growth and is expected to expand considerably in the coming years.
The global exosome-based cancer therapy CDMO market is witnessing rapid growth as biopharma firms partner with CDMOs to develop and manufacture novel exosome therapeutics. The global exosome-based cancer therapy CDMO market is witnessing robust growth driven by the growing demand for personalized treatment, increasing prevalence of cancer, rapid advancements in exosome isolation, and rising investments in healthcare infrastructure. This report covers market trends, production volumes, technological developments, and competitive dynamics across North America, Europe, and APAC between 2025 and 2030.
The global cell and gene therapy quality control and analytics market is expanding rapidly with AI-driven data analysis, automation, and real-time quality assessment tools. The market growth is driven by the increasing prevalence of genetic disorders and advancements in gene editing technologies.
The global oncolytic virus-based gene therapy market is advancing as engineered viruses emerge as a powerful approach to target, infect, and kill tumor cells while stimulating immune response. The market is experiencing significant growth, primarily due to the rising incidence of cancer, the increasing demand for innovative cancer treatments, and the unique dual mechanism of action of the oncolytic virus that both destroys tumors and stimulastes the immune system. This growth is further accelerated by advancements in genetic engineering, viral vector technology, and the development of effective combination therapies, especially with immune checkpoint inhibitors.
The global cell encapsulation technology market is witnessing strong growth as therapeutic cells are encapsulated to protect them from immune rejection and ensure sustained efficacy. The growth of the market is driven by rising demand for efficient sample management solutions and advancements in automation and storage technologies.
The global in-situ hybridization market size accounted for USD 1,870 million in 2025 and is predicted to increase from USD 2,010 million in 2026 to approximately USD 3,600 million by 2034, expanding at a CAGR of 7.53% from 2025 to 2034. This market is growing due to the rising prevalence of chronic diseases and advancements in technology, particularly in precision diagnostics and personalized medicine.
The global in vivo cell reprogramming market is witnessing significant growth as researchers explore in-body cellular conversion for tissue repair and organ regeneration. The market for in vivo cell reprogramming represents a rapidly evolving field focused on the transformative potential of reprogramming cells within living organisms. This innovative approach is poised to have a significant impact on therapeutic developments and regenerative medicine, reflecting the growing interest and advancements in the life sciences sector. As research progresses, the market is expected to expand, offering new solutions and opportunities in the healthcare sector.
The engineered TCR (T-cell receptor) therapy market is emerging as a significant advancement in cancer treatment, providing the capacity to target intracellular tumor antigens that are inaccessible to CAR-T therapies. With continuing clinical trials and regulatory approvals, this technology is gaining traction and demonstrates great promise in treating solid tumors. In the years to come, the market is anticipated to be greatly driven by expanding research in immunotherapy, gene editing, and neoantigens.
The global bacterial therapeutics market is witnessing strong growth as engineered bacteria and live biotherapeutics offer new treatment options for various diseases. The market is experiencing significant growth, reflecting advances in microbiome-based treatments. With increasing research and development, this sector is anticipated to expand substantially over the next decade.
The global phage therapy market size accounted for USD 1.24 billion in 2024 and is predicted to increase from USD 1.29 billion in 2025 to approximately USD 1.85 billion by 2034, expanding at a CAGR of 4.08% from 2025 to 2034. This market is rising due to the increasing global crisis of antibiotic resistance and the rising demand for precision antimicrobial solutions.
The global AI-powered drug formulation market is witnessing rapid growth as AI technologies enable pharmaceutical companies to design optimized drug formulations efficiently and accurately. The market growth is attributed to the increasing integration of advanced AI technologies in drug formulation processes, enabling faster development and reduced costs.
The global automated bio-banking market size accounted for USD 2.45 billion in 2024 and is predicted to increase from USD 2.73 billion in 2025 to approximately USD 7.27 billion by 2034, expanding at a CAGR of 11.48% from 2025 to 2034. The growth of the automated bio-banking market is driven by rising demand for efficient sample management, digital integration, and advancements in automation and storage technologies.
The global liquid filtration for pharmaceutical market is witnessing strong growth as the industry prioritizes sterile processing, purity assurance, and contamination control. This market is growing due to increasingly stringent regulatory guidelines for product safety and purity.
The global bioinformatics-as-a-service (BaaS) market size was calculated at USD 3.75 billion in 2024 and is predicted to increase from USD 4.29 billion in 2025 to approximately USD 14.56 billion by 2034, expanding at a CAGR of 14.53% from 2025 to 2034. The bioinformatics-as-a-service (BaaS) market is an emerging sector that offers computational solutions for analyzing biological data.
The global oncolytic virus therapy market size accounted for USD 3.28 billion in 2024 and is predicted to increase from USD 3.71 billion in 2025 to approximately USD 11.13 billion by 2034, expanding at a CAGR of 13.00% from 2025 to 2034. The oncolytic virus therapy market is witnessing steady growth, driven by rising cancer prevalence, increased clinical trials, and growing adoption of innovative viral-based treatments worldwide.
